Bluebird bio's gene therapy fertility support program gets thumbs down from HHS inspector general
The door is closing on bluebird bio’s attempt to secure Medicaid coverage for its fertility support program, which is already offered to patients with commercial insurance who receive its gene therapies. On Monday, the Office of the Inspector General (OIG) …